递归分割分析显示根治性前列腺切除术后切缘阳性且未接受辅助激素或放疗患者8年生化复发风险亚组
该多机构回顾性研究纳入2002至2010年间切缘阳性根治性前列腺切除术后未接受辅助激素或放疗的210例患者,中位随访105个月,89例出现PSA复发。递归分割分析基于Gleason分级和切缘范围得出5个风险组,8年生化复发无生存率从最低危组(GG1、切缘≤2 mm)的92%至最高危组(GG3-5、切缘≥3 mm)的11%。作者认为低级别且切缘轻微受累者复发风险很低,或许可以免除术后放疗。
要点
- 递归分割分析基于Gleason分级和切缘范围得出5个离散风险组。
- 8年生化复发无生存率最低危组(GG1、切缘≤2 mm)为92%,最高危组(GG3-5、切缘≥3 mm)为11%。
- 作者认为低级别且切缘轻微受累者复发风险很低,或许可以免除术后放疗。
核心结论
- 该回顾性研究提示,或可利用常规获取的临床和病理变量对切缘阳性根治性前列腺切除术后患者进行风险分层。
- 低级别肿瘤且切缘轻微受累者复发风险很低,或许可以免除术后放疗;而更高级别和切缘更广泛受累者或可从辅助或早期挽救放疗中获益。
研究设计与样本
- 利用多机构数据库回顾性筛选2002至2010年间接受根治性前列腺切除术、有随访PSA记录的临床局限期前列腺癌患者。
- 排除病理精囊或淋巴结侵犯、转移性疾病、术前PSA≥30、或接受辅助(非挽救)放疗或激素治疗者。
- 主要终点为生化复发无生存,PSA失败定义为PSA>0.10 ng/mL且上升,或在挽救干预时。
- 采用Kaplan-Meier法估计生化复发无生存,并应用递归分割分析(基于累积或单次最大切缘范围和根治性前列腺切除术时的Gleason分级)识别与生化复发无生存相关的变量。
主要发现
- 中位随访105个月,210例切缘阳性根治性前列腺切除术患者符合分析条件,其中89例出现PSA复发。
- 中位年龄61岁(范围43-76),中位术前PSA 5.8 ng/mL(范围1.6-26.0)。
- 递归分割分析得出5个离散风险组,最低危组(GG1、切缘≤2 mm)8年生化复发无生存率为92%,最高危组(GG3-5、切缘≥3 mm)为11%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The cohort of patients with locally advanced prostate cancer (PC) and positive surgical margin(s) at radical prostatectomy (RP) who would benefit from salvage or adjuvant treatment is unclear. This study examines the risk of prostate-specific antigen (PSA) relapse in a large population of men with PC after margin-positive RP. METHODS AND MATERIALS: Using a multi-institutional database, patients with clinically localized PC who underwent RP between 2002 and 2010 with recorded follow-up PSA were retrospectively selected. Patients were excluded for pathologic seminal vesicle or lymph node involvement, metastatic disease, pre-RP PSA ≥ 30, or adjuvant (nonsalvage) radiation therapy or hormone therapy. The primary endpoint was biochemical relapse free survival (bRFS), where PSA failure was defined as PSA > 0.10 ng/mL and rising, or at salvage intervention. The Kaplan-Meier method was employed for bRFS estimates; recursive partitioning analysis using cumulative or single maximal margin extent (ME) and Gleason grade (GG) at RP was applied to identify variables associated with bRFS. RESULTS: At median follow-up of 105 months, 210 patients with positive margins at RP were eligible for analysis, and 89 had experienced PSA relapse. Median age was 61 years (range, 43-76), and median pre-RP PSA 5.8 ng/mL (1.6-26.0). Recursive partitioning analysis yielded 5 discrete risk groups, with the lowest risk group (GG1, ≤ 2 mm ME) demonstrating a bRFS of 92% at 8 years compared with the highest risk group (GG3-5, ≥ 3 mm ME) of 11%. CONCLUSIONS: This retrospective study suggests that it may be possible to risk-stratify patients undergoing margin-positive RP using commonly acquired clinical and pathologic variables. Patients with low-grade tumors and minimally involved margins have a very low recurrence risk and may be able to forego postprostatectomy radiation. Meanwhile, those with higher grade and greater involvement could benefit from adjuvant or early salvage radiation therapy.
引用
- Seyedin SN, Watkins JM, Mayo Z, et al. A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy. Adv Radiat Oncol. 2021. PMID: 34934861. doi:10.1016/j.adro.2021.100778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。